Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ONXX -- Ignore unavailable to you. Want to Upgrade?

To: Elmer who wrote (390)	8/1/2000 7:55:13 PM
From: Elmer	Respond to of 810

Vical (another gene therapy company) just announced favorable Phase II results in a treatment for head and neck cancer. Gene therapy just got real Message 14146873

To: Elmer who wrote (390)	8/2/2000 8:54:00 AM
From: Oak Tree	Read Replies (1) \| Respond to of 810

Dave, which stock will go higer? "I think the stock will go higher is, that with this publicity, it's market capitalization ($200 million) will trend up to that of a bunch of recent biotech IPOs that are all trading north of $1.2 billion. Those companies' technology is comparable in potential to that of ONXX. Check the IPOs out EXEL, MAXY, TLRK, ILMN, DVSA and CALP. " Many of these stocks are already valued at over a billion even if they don't yet make any money and certainly no profit.